Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 20 pharmaceutical deals announced in Q1 2023, worth a total value of $50.2bn. The $43bn acquisition of Seagen by Pfizer was the industry’s largest disclosed deal. GlobalData’s New Drug Approvals and Their Contract Manufacture report provides critical insight into the contract manufacturing organization (CMO) industry by analysing relative performance of major CMOs by number of drug

Contract Manufacturing 214

Contract Manufacturing Drugs Manufacturing Vaccination 214

Drug Patent Watch

MAY 28, 2023

This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52

Pharmaceutical Technology

MAY 28, 2023

AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Ultomiris (ravulizumab) to prevent relapses in patients with neuromyelitis optica spectrum disorder (NMOSD), including neuromyelitis optica. The rare and debilitating autoimmune condition NMOSD affects the central nervous system (CNS), including optic nerves and the spine.

Trials 130

Trials 130

Drug Discovery World

MAY 28, 2023

The International Day of Action for Women’s Health has been celebrated on 28 May every year since 1987. In 2023, DDW’s Megan Thomas looks at how the drug discovery industry is taking action in this arm of healthcare. Context A 2023 McKinsey study revealed despite the exponential growth in data generated across the healthcare ecosystem, notable gaps remain in women’s health.

Drugs 52

Drugs Vaccination Vaccine Research 52

Advertisement

Clinical Supply

Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 12 pharmaceutical deals announced in Q1 2023, worth a total value of $43.4bn. The $43bn acquisition of Seagen by Pfizer was the industry’s largest disclosed deal. A detailed classification of therapy and technologies, regulatory and market access details and pipeline analysis for immuno-oncology are included in GlobalData’s Immuno-Oncology – Thematic Research report.

Research 130

Research Marketing 130

Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that virtual care accounted for 6 pharmaceutical deals announced in Q1 2023, worth a total value of $426.2m. The $250m merger of Clearday and Viveon Health Acquisition and 98point6 was the industry’s largest disclosed deal. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on ma

Marketing 130

Marketing 130